The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.
about
HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZHistorical review of the causes of cancerMolecular Studies of HTLV-1 Replication: An UpdateHow does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selectionRNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event.HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometryDetection of monoclonal integration of bovine leukemia virus proviral DNA as a malignant marker in two enzootic bovine leukosis cases with difficult clinical diagnosisApplication of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome.T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipientsHTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model"The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.Retrovirus Integration Database (RID): a public database for retroviral insertion sites into host genomesImpact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model.Risk stratification of adult T-cell leukemia/lymphoma using immunophenotypingAdult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.Integration site and clonal expansion in human chronic retroviral infection and gene therapy.Cancer whole-genome sequencing: present and future.Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization.Human T-cell leukemia virus-associated malignancy.Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesisHuman T-cell leukaemia virus type 1: parasitism and pathogenesis.Tumour virology in the era of high-throughput genomics.Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.High-Throughput Mapping and Clonal Quantification of Retroviral Integration Sites.[Intercellular transmission of HTLV-1: not all mechanisms have been revealed].Selection for avian leukosis virus integration sites determines the clonal progression of B-cell lymphomas.Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.Whole Genome Sequencing Analysis for Cancer Genomics and Precision Medicine.Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.
P2860
Q26744330-27132BB2-9FCF-41C6-AED7-C82D17ADBE6EQ26767036-11440958-806F-4C6E-AEC5-1FD3EC80A9A3Q26772930-CB9FC810-23C4-4DFB-8849-3B54F65E3FDAQ26785554-C3DA1195-307F-4441-8F15-A701A469B581Q28088514-F7ECEDDD-8096-4748-8EE0-243F8D1E5E6DQ30252424-52896AF3-FD90-4D16-B3B8-6AB9B14955A8Q33759081-2E91EA6C-6AA9-476B-9FF1-E156C773B03AQ34059550-64B57886-A440-4812-8230-11CD3DF6A369Q34316662-BC0D25B9-F468-44FB-9C6B-FA1F9317E2EBQ35674201-3F260211-CD01-4090-A447-4101F0AC4E70Q35924180-FBB5B397-AB20-4B75-85C3-9236C40BB598Q36056547-F044EBD3-AA1D-4069-9049-7599424462F3Q36205736-5A7F37EE-D232-4CCD-8012-9E87430C30A0Q36267687-099B231C-962A-4283-87B3-4F35DC04771CQ36446222-D25386FC-EFBB-4556-80AD-6146AD08D7E8Q36509597-C3CB01D8-BBD8-4FE9-A41E-6A763388F74AQ36710444-F29F3658-4207-44C6-B1B3-56AA74B16C6EQ37064393-30A58D81-15FB-4626-B3EB-A6C5D76FE5D3Q37588235-C789678D-69D5-417C-B4FE-001A588819D5Q37609458-CCB88616-2F4B-448E-AFEC-1A576C23E998Q37731757-4714AB19-FD67-4398-8937-7668FCF5382DQ38264568-0DD0513B-2355-4EA0-BB47-06BCD91A973CQ38395966-FCCFC24B-C179-49FF-AF9B-C2B08433C0F1Q38538043-A2D0DFCF-99C3-4638-96B6-FA87E71428C4Q38683761-2ABB2DFF-6DA3-4006-AEDB-79AB4CD09E3AQ38824662-33FE9BE2-8F10-4526-920B-87A81ACE47C6Q38952071-387925A7-2E9A-48CD-BAF2-BA108F44E83CQ39311297-961DEB33-D111-439E-AD50-C5404B11261EQ40046615-BDFACE3C-53C5-490F-BA04-3D9BFD6F4BB2Q40046673-6FC41C81-312F-4E99-8E44-1E3E1E70E332Q40217765-536F5A31-C38B-4413-8220-CD018E53C99FQ40267353-EF33C2E7-C7A7-4F99-BB5C-A24244A533A4Q41119284-5B99C1ED-F0F6-4891-AB76-D24D6B0013A5Q45325336-C05EACD8-49C7-4D82-9F8E-0DF8BDB8EB3AQ45325985-74D22A8E-F626-4C2B-8324-4782A5C57F7FQ47170880-9553FB99-28A4-4C05-9DCC-405560E61D2EQ47725702-1610026E-812A-4722-9DC2-B9A2A49D0CECQ50000058-81F99AF8-C250-42FB-86EC-39EE9AC2722AQ53635366-ADD3BC86-FA83-4C4C-A649-9AF24CFF0501Q54246489-5854B17E-C006-4706-89F2-5DD78B668A05
P2860
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@ast
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@en
type
label
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@ast
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@en
prefLabel
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@ast
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@en
P2093
P2860
P50
P1433
P1476
The role of HTLV-1 clonality, ...... dult T-cell leukemia/lymphoma.
@en
P2093
Charles R M Bangham
Graham P Taylor
Heather Niederer
Letizia Foroni
Lucy B Cook
Mikel Valganon
P2860
P304
P356
10.1182/BLOOD-2014-02-553602
P407
P577
2014-04-15T00:00:00Z